Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07348406Phase 2Recruiting
Phase 2, randomised trial in Mild Cognitive Impairment (MCI) (2 arms), sponsored by Texas Tech University Health Sciences Center. Primary endpoint: fMRI measures at 3 months. Started Mar 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07348406.